COMMUNIQUÉS West-GlobeNewswire

Eloxx Pharmaceuticals Announces Pricing of $30.0 Million Public Offering of Common Stock
20/06/2019
WALTHAM, Mass., June 20, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (“Eloxx”) (Nasdaq: ELOX) today announced the pricing of an underwritten public offering of 3,333,334 shares of its common stock at a price to [...]
Wildflower Featured in CannabisNewsAudio Broadcast Discussing Profitability of Cannabis Sector
20/06/2019
NEW YORK , June 20, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsAudio – Wildflower Brands Inc. (OTCQB:WLDFF) (CSE:SUN) announces the availability of an audio press release titled: “Searching for the Next Super Nova.” To [...]
REPEAT: AgraFlora Organics Welcomes Collection of Industry Analysts, Institutional Investors and Media Personnel to June 25th Delta Greenhouse Tour; Broadcast To Be Made Available Online Via Corporate Website
20/06/2019
VANCOUVER, British Columbia, June 20, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF ), a growth oriented and diversified [...]
Progenics Pharmaceuticals to Initiate a Basket Trial by Year End to Support an Expanded Label for AZEDRA® (iobenguane I 131) in Multiple MIBG Avid Neuroendocrine Tumors
20/06/2019
NEW YORK, June 20, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), (“Progenics” or the “Company”), an oncology company developing innovative targeted medicines and artificial intelligence to find [...]
Agritek Holdings, Inc. Announces Execution of Term Sheet for Cash Infusion of Up to $2.5 Million Dollars from Private Banking Partner and Equity Line for Expansion of Multi-State Cannabis Operations
20/06/2019
LOS ANGELES, CA, June 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Agritek Holdings, Inc. (OTC: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector and consultant [...]
Fluidigm Highlights New Advancements in Deep Cellular Profiling from Circulation to Tissue at CYTO 2019
20/06/2019
Leading translational and clinical researchers will showcase how Fluidigm products are revolutionizing highly multiplexed cell and tissue characterization, biomarker discovery and therapeutic research development in [...]
Arvinas to Present at the BMO Prescriptions for Success Healthcare Conference
20/06/2019
NEW HAVEN, Conn., June 20, 2019 (GLOBE NEWSWIRE) -- Arvinas Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on protein degradation, today announced that Ian Taylor, Ph.D., Chief [...]
Cybrexa Therapeutics Closes $13.4M in Series B1 Funding Round
20/06/2019
NEW HAVEN, Conn., June 20, 2019 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a biotechnology company developing a new class of cancer therapeutics through its alphalex™ tumor targeting platform, today announced the [...]
Predictive Technology Group Announces the Presentation of New Genetic Findings in Endometriosis at the 35th Annual Meeting of the European Society of Human Reproduction and Embryology
20/06/2019
SALT LAKE CITY, June 20, 2019 (GLOBE NEWSWIRE) -- Predictive Laboratories, a wholly owned subsidiary of Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease [...]
BeyondSpring Set to Join FTSE Russell 3000® Index
20/06/2019
NEW YORK, June 20, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, announced today that it will join the FTSE Russell 3000 [...]
Optinose to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference
20/06/2019
YARDLEY, Pa., June 20, 2019 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive [...]
BioDelivery Sciences Named to the Russell 3000® Index
20/06/2019
Recognition is a Result of Company’s Performance over the Last 12 Months RALEIGH, N.C., June 20, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is set to be added to the broad-market [...]
Spero Therapeutics Announces Collaboration with Bill & Melinda Gates Medical Research Institute to Develop SPR720 for Tuberculosis
20/06/2019
CAMBRIDGE, Mass., June 20, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in [...]
OPKO Health Submits De Novo Request to the U.S. FDA for the 4Kscore® Test
20/06/2019
MIAMI, June 20, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces that the Company has submitted a de novo request to the U.S. Food and Drug Administration (FDA) seeking regulatory clearance for the [...]
Albireo Announces Launch of “PFIC Voices”
20/06/2019
New Initiative to Create Awareness and Understanding of Life-Threatening Pediatric Liver Disease Announced new PFIC Voices website, www.PFICvoices.com BOSTON, June 20, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. ( [...]
VBI Vaccines to Present at the BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference
20/06/2019
CAMBRIDGE, Mass., June 20, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, [...]
Alimera’s ILUVIEN® Receives Positive NICE Recommendation for Non-Infectious Posterior Uveitis
20/06/2019
NICE decision is key milestone expanding access to patients in the United Kingdom ATLANTA, June 20, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a leader in the commercialization and [...]
BioSig Technologies Issues June 2019 Shareholder Letter
20/06/2019
Top Tier New Corporate Talent and First Successful Clinical Results from Leading Medical Institutions Pave Way for Commercial Rollout Santa Monica, CA, June 20, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ [...]
BeiGene Presents Pivotal Phase 2 Clinical Results of Zanubrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma at the 15th International Conference on Malignant Lymphoma (ICML)
20/06/2019
Company to Host Investor Conference Call and Webcast of Mid-2019 Clinical Data Updates Today, Thursday, June 20 at 8:00 a.m. EDT CAMBRIDGE, Mass. and BEIJING, China, June 20, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. ( [...]

Pages